Scientists from the Institute of Organic Chemistry and Biochemistry (IOCB) in collaboration with the University of Tübingen in Germany and the Faculty of Science at Charles University have developed a new type of contrast agent that can be used simultaneously in magnetic resonance imaging (MRI) and positron emission tomography (PET). This groundbreaking discovery promises significant improvements in diagnostics and subsequent treatment, particularly for kidney diseases and tumors. It addresses a key limitation that has so far hindered the full integration of these imaging techniques.

The research was published in the renowned scientific journal Angewandte Chemie.

You can read the full article here:

https://www.uochb.cz/cs/novinky/629/nova-pet-mri-kontrastni-latka-vyvinuta-v-uochb-slibuje-vcasne-odhaleni-skrytych-nemoci

(Photo: Tomáš Belloň/IOCB)

‍